Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis: a four-point guidance
More details
Hide details
Submission date: 2018-01-18
Acceptance date: 2018-01-29
Online publication date: 2018-02-28
Publication date: 2018-02-28
Reumatologia 2018;56(1):1-2
In our Editorial we highlight the possibility that polymyalgia rheumatica (PMR) can have normal values of both erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) concentrations at the time of diagnosis. We reported all the data in the literature about this subset of disease and discussed the most relevant hypotheses about the possibility that these biomarkers can be not raised in an auto inflammatory disease such as PMR. The utility of an ultrasound examination of shoulder and hip girdles and the measurement of other biomarkers in adjunct to ESR and CRP represented other points of discussion. In conclusion, we propose a four-point guidance on how to investigate PMR when normal ESR and CRP coexist.
Gonzalez-Gay MA, Matteson EL, Castaneda S. Polymyalgia reumatica. Lancet 2017; 390: 1700-1712.
Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996; 35: 1161-1168.
Cantini F, Salvarani C, Olivieri I, et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 2000; 30: 17-24.
González-Gay MA, Rodríguez-Valverde V, Blanco R, et al. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome. Arch Intern Med 1997; 157: 317-320.
Doria A, Zen M, Bettio S, et al. Autoinflammation and autoimmunity: brindging the divide. Autoimmun Rev 2012; 12: 22-30.
Kermani TA, Schmidt J, Crowson CS, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012; 41: 866-871.
Manzo C, Camellino D. Polymyalgia rheumatica (PMR): diagnostic and therapeutic issues of an apparently straightforward disease. Recenti Prog Med 2017; 108: 221-231.
Zaccaria A, Latinakis G, Olivieri M, et al. The support of the ultrasonography of the shoulder in the diagnosis of polymyalgia rheumatica with normal erythrocyte sedimentation rate. Reumatismo 2009; 61: 290-297.
Mackie SL, Koduri G, Hill CL, et al. Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review. RMD Open 2015; 13; 1: e000100. 10.
McCarthy E, MacMullan PA, Al-Mudhaffer S, et al. Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica. Rheumatology 2013; 52: 465-471.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top